Evidence map›Paper›PMID 41839677›Full record

ArticleJournal, genetic engineering & biotechnology2026

Tissue culture and elicitor applications for sustainable secondary metabolite enhancement in Mentha longifolia (L.) Huds.

Shaimaa N Mizil

Abstract read
In one paragraph

Article in Journal, genetic engineering & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Shaimaa N MizilDepartment of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq. Electronic address: shaymaa.m1979@uomustansiriyah.edu.iq.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mentha longifolia (L.) Huds., an aromatic herb from the Lamiaceae family, is well known for its bioactive compounds and high demand in the food, cosmetic, and pharmaceutical industries. To overcome several challenges due to overharvesting, disease, and climate change, a dependable, sustainable production method for the important secondary metabolites is necessary, and steady metabolite production under regulated circumstances may be achievable through plant tissue culture. M. longifolia callus cultures were used in this research to evaluate the effects of elicitors, methyl jasmonate (MeJA), salicylic acid (SA), and yeast extract (YE) on biomass accumulation and metabolite synthesis. Murashige and Skoog (MS) medium fortified with 1 mg/l 2,4-D was used to produce calli formed from leaves, which were then subjected to varying concentrations of elicitor. HPLC, quantitative analysis of phenolics, flavonoids, alkaloids, and essential oils were evaluated. The findings indicated that MeJA, at 100 µM supplementation, significantly increased biomass (dry weight increased by 65.12%) and metabolite accumulation, producing the significant levels of phenolics (95.3 ± 4.8 mg GAE/g DW), flavonoids (59.7 ± 3.5 mg QE/g DW), and essential oil content (3.28 ± 0.4% w/w). Both SA and YE increased the accumulation of metabolites, although SA (150 µM) was the most efficient at accumulating alkaloids (2.1 ± 0.1 mg/g DW). In response to the elicitors, the key secondary metabolites biosynthetic genes (PAL, CHS, TDC, and HMGR) were found to be upregulated, with MeJA eliciting (∼5 fold) the highest transcriptional response significantly. All the findings indicate that the use of elicitors, particularly MeJA, showed promise in augmenting the in-vitro production of important secondary metabolites from M. longifolia.

Indexed as

Callus inductionElicitorsMenthalongifoliaSecondary metabolismTraditional cultivation

Identifiers

PMID41839677
PMCPMC12854970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.